0576-88813233
吉列替尼 Gilteritinib (ASP2215) 是一种有效的 ATP 竞争性的 FLT3/AXL 抑制剂,IC50 分别为 0.29 nM/0.73 nM。
[1]. ASP2215, a novel FLT3/AXL inhibitor: Preclinical evaluation in acute myeloid leukemia (AML). 2014 ASCO Annual Meeting.
[2]. Mori M, et al. Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia. Invest New Drugs. 2017 Oct;35(5):556-565.
版权所有 Copyright(C) 2018-2024 台州市科瑞生物技术有限公司